Skip to content

Evaluation the Feasibility of the FOSTI Device

Evaluation the Feasibility of the FOSTI Device Accurately and in a Real Time Way to Differentiate Malignant From Benign Tissue (Performed ex Vivo) in Cancer Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00791609
Enrollment
50
Registered
2008-11-14
Start date
2008-03-31
Completion date
Unknown
Last updated
2008-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

cancer

Brief summary

Feasibility of accurate differentiation between malignant and benign tissue using the FOSTI device on surgically removed tissue

Detailed description

Characterization of the optical fiber sensor's interaction with the tissue. Creating a database of tissue lesions and their 'optical signature' (lesion classifier). Optimization of the FOSTI device by minimizing the false-positive and false-negative results.

Interventions

None listed

Sponsors

Optivasive Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Subjects of all ages. * Subject is able, agree and sign the Informed Consent Form.

Exclusion criteria

* Subject has any conditions, which precludes compliance with study

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026